I-spy covid trial sponsored by quantum leap healthcare collaborative reports assessment of narsoplimab for treatment of critically ill patients with covid-19

San francisco & seattle--(business wire)--quantum leap healthcare collaborative (qlhc), sponsor of the i-spy covid trial, and omeros corporation (nasdaq: omer), developer of the investigational agent narsoplimab, announced that enrollment has been closed and data have been analyzed in the narsoplimab arm of the i-spy covid trial. the analysis in the randomized patient population, including those who declined treatment after randomization, shows that the addition of narsoplimab to treatment of c
OMER Ratings Summary
OMER Quant Ranking